Diego Garrido is a visionary biologist and engineer specializing in longevity, genomics and “bio-design” innovation. As CEO and Director of Kultiva Life Sciences, he leads strategic research programs that aim to translate advanced gene‐therapy, biomarker and longevity science into accessible therapeutic solutions.

Garrido’s background combines ecological systems thinking, molecular biology and synthetic genomics—an interdisciplinary foundation that informs his approach to tackling the biological challenges of aging and resilience. Under his leadership, Kultiva has pursued multi-year research initiatives focused on identifying biomolecular targets of aging, developing client-ready therapeutic prototypes, and aligning those innovations with regulatory and translational pathways.

His work is distinguished by a deep commitment to paradigm-shifting health- science: moving beyond incremental wellness into high-impact longevity interventions. Garrido often speaks to both scientific and investor audiences about how emerging “-omics”, regenerative biology, and precision interventions can reshape human healthspan, performance and vitality. With an eye on global scalability, he brings a combined scientific rigour and entrepreneurial mindset to the frontier of longevity medicine.